BS
Bhupendra Singh Shekhawat
About Bhupendra Singh Shekhawat
Data last updated:
Bhupendra Singh Shekhawat has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Brown & Black Bio Private Limited. Formerly with 3 companies, such as Werochem Healthcare Private Limited and I G Pharma Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Brown & Black Bio Private Limited U24232RJ2012PTC038029 | Director | 02 May 2013 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Werochem Healthcare Private Limited U24290RJ2022PTC083657 | Director | 08 Sep 2022 | 2022 | Active |
| I G Pharma Limited U24232UR2005PLC011213 | Additional Director | 04 Aug 2011 | 2005 | Active |
| Bullford World Limited U24232RJ2011PLC034102 | Director | 08 Feb 2011 | 2011 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhupendra Singh Shekhawat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhupendra Singh Shekhawat
Bhupendra Singh Shekhawat has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Brown & Black Bio Private Limited. Formerly with 3 companies, such as Werochem Healthcare Private Limited and I G Pharma Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Bhupendra Singh Shekhawat is associated with 1 company as Director.
Bhupendra Singh Shekhawat has expertise in General Business, Healthcare.
Bhupendra Singh Shekhawat has 15 years in corporate governance.